We help
biotech, medtech, and cosmetic R&D teams
make the right research, funding, and partnership decisions — before execution becomes expensive
Clarity before capital. Confidence before CROs.
Evidence-based validation, feasibility studies, and strategic guidance for life science innovation.
Response within 24-48 hrs • NDA available upon request
Most early-stage biotech, medtech, and cosmetic R&D do not fail because of weak science.
They fail when decision-critical research, funding, and partnership decisions are made too early.
In practice, this leads to:
✅ Studies that do not answer decision-critical questions.
✅ Funding pursued without clear scientific and market positioning
✅ CROs selected before scientific and strategic alignment
✅ Momentum lost as regulatory and investor scrutiny increases
THESE ARE NOT EXECUTION PROBLEMS.
They are decision problems
Why PROMAFUN CRIO?
PROMAFUN CRIO operates before execution – where outcomes are determined.
We work with early-stage and scale-ups in biotech, medtech, and cosmetic R&D teams at critical transition points: before funding rounds, CRO selection and market entry.
PROMAFUN CRIO acts as a Contract Research Intermediary (CRI), not a CRO, not a traditional consultant, but the strategic layer where scientific, financial, and operational decisions are shaped before they become costly.
We help teams design, fund, and execute with clarity, across four tightly connected domains: rearch validation, funding strategy, partnership alignment, and execution readiness.
Not a CRO
We do not operate laboratories, we design decision-critical studies and guide you in selecting and managing the right CRO partners for execution.
Not a Grant factory
We do not mass-produce applications, we align your funding strategy with your scientific and commercial positioning.
Not a Generic Consultancy
We do not stop at advice, we stay engaged until your key scientific, financial, and operational decisions are validated.
Our Services — Strategic Support for Research & Health Innovation
From proposal development to project implementation.
Clear guidance. Scientific rigor. Real-world impact.
Backed by EU & Dutch funding programmes:
Funding Strategy & Grant Support
Grant writing embedded in your R&D strategy and development planning.
Our support includes:
• Non-dilutive funding strategy & call selection
• Grant writing & proposal development
• Grant management & coordination
• Proposal review, positioning & evaluation alignment
Business Development
From scientific promise to strategic traction
We help translate scientific innovation into clear value propositions, partner discussions and investor-ready material grounded in a coherent strategy.
Learn More About Our Services
〉Go-to-market & Business Strategy
〉Roadmapping from Lab to Launch
Dissemination & Exploitation
Decision-centric impact, not just visibility
We support dissemination and exploitation strategies that prepare results for scrutiny at future decision points, funding, regulation, industrial uptake and market entry.
Learn More About Our Services
Our Contract Research Intermediary (CRI) Services
Preclinical Strategy & CRO Navigation
Validate feasibility, CRO fit, and study requirements before committing to outsourced studies.
Our support includes:
• Study design & feasibility assessment
• Operational coordination
• Compliance & Quality alignment
• Pharmacology & Toxicology studies
• Data Management & Biostatistics
• Efficacy studies for cancer, bacterial & virus infections
〉Efficacy studies for cancer and virus infections vaccines drug compounds and antibodies
Instant Support
READY TO ACCELARATE YOUR RESEARCH AND BUSINESS? LET’S EXPLORE HOW WE CAN SUPPORT YOUR NEXT STEP.
FILL THE FORM AND OUR TEAM WILL GET BACK AT YOU.
Contact Us
Contact Us For Additional Info
Not ready for a full engagement yet?
Start with an Entry-Level Strategic Assessment
.
A focused, expert-led review to determine your current readiness for funding and strategic positioning.
Starting here is a low-risk entry point before committing to larger projects.
Many early-stage teams invest time and money before key assumptions are fully tested.
Our entry-level assessments help you identify gaps, risks, and priorities, so your next step is informed, not speculative.
PROMAFUN CRIO Blog:
Navigating the Future of Clinical Research – Insights, Trends, and Strategies for Success